Sandbox parminder: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
'''For patient information click [[{{PAGENAME}} (patient information)|here]]'''.
Most boils run their course within 4 to 10 days. For most people, self-care by applying a warm compress or soaking the boil in warm water can help alleviate the pain and hasten draining of the pus (colloquially referred to as "bringing the boil to a head"). Once the boil drains, the area should be washed with antibacterial soap and bandaged well.
{{West nile virus}}


{{About1|West nile virus causes}}
For recurring cases, sufferers may benefit from diet supplements of [[Vitamin A]] and [[Vitamin E|E]].
{{CMG}}; {{AE}} {{MJM}}


{{SK}} West Nile, WNV
In serious cases, prescription oral [[antibiotic]]s such as [[dicloxacillin]] (Dynapen) or [[cephalexin]] (Keflex), or topical antibiotics, are commonly used. For patients allergic to penicillin-based drugs, [[erythromycin]] (E-base, Erycin) may also be used.


==[[West nile virus overview|Overview]]==
However, some boils are caused by a [[Antibiotic resistance|super bug]] known as Community-Associated Methicillin-Resistant Staphylococcus Aureus, or [[MRSA|CA-MRSA]]. [[Bactrim]] or other [[sulfa]] drugs must be prescribed relatively soon after boil has started to form. [[MRSA]] tends to increase the speed of growth of the infection.


==[[West nile virus historical perspective|Historical Perspective]]==
[[Magnesium sulfate]] paste applied to the affected area can prevent the growth of bacteria and reduce boils by absorbing pus and drying up the lesion.


==[[West nile virus causes|Causes]]==
*If [[fever]], [[carbuncle]]s, recurrences -> systemic abx vs. [[S. aureus]]
:*[[Dicloxacillin]] 500 mg po q6h x 10-14 days
:*Alternatives: 
::*[[Cephalexin]] 250 mg qid
::*[[Clindamycin]] 150 mg qid
::*[[Bactrim]]
:*Abx
::*[[Mupirocin]] 2% ointment to anterior nares bid x 5 days
:::*Eliminates [[S. aureus]] nasal carriage for up to 90 days
:::*Also effective against [[MRSA]], but 40% recur on maintenance Rx
::*[[Rifampin]] 600 mg po qd x 10 days
:::*Eliminates nasal carriage for up to 3 months
:::*Consider in patients who have failed other preventive measures
:::*Rx acute recurrence simultaneously with [[dicloxacillin]] or alternative x 10d
::*[[Clindamycin]] 150 mg po qd x 3 months (suppressive regimen)
:::*Shown in one study to decrease frequency of recurrence


==[[West nile virus pathophysiology|Pathophysiology]]==
==References==
 
{{Reflist|2}}
==[[West nile virus epidemiology and demographics|Epidemiology & Demographics]]==
[[Category:Dermatology]]
 
[[Category:Infectious disease]]
==[[West nile virus epidemiology and demographics|Risk Factors]]==
[[Category:primary care]]
 
==[[West nile virus screening|Screening]]==
 
==[[West nile virus differential diagnosis|Differentiating West nile virus from other Diseases]]==
 
==[[West nile virus natural history|Natural History, Complications & Prognosis]]==
 
==Diagnosis==
[[West nile virus history and symptoms|History & Symptoms]] | [[West nile virus physical examination|Physical Examination]] | [[West nile virus laboratory tests|Lab Tests]] | [[West nile virus case studies|Case Studies]]
 
==Treatment==
[[West nile virus medical therapy|Medical Therapy]] | [[West nile virus primary prevention|Primary Prevention]] | [[West nile virus future or investigational therapies|Future or investigational therapies]]
 
==Related Chapters==
*[[CCR5]]
 
==[[West nile virus resources|Resources]]==
 
 
 
[[es:Virus del Nilo Occidental]]
[[fr:Virus du Nil occidental]]
[[ja:ウエストナイル熱]]
[[pt:Nilo ocidental]]
[[zh:西尼羅河病毒]]


[[Category:Needs overview]]


{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WS}}
{{WikiDoc Sources}}
 
[[Category:Disease]]
[[Category:Infectious disease]]
[[Category:Neurology]]
 
[[Category:Flaviviruses]]
[[Category:Viral diseases]]
[[Category:Zoonoses]]
[[Category:Tropical disease]]
[[Category:Insect-borne diseases]]
 
 
 
 
 
 
 
 
{{West nile virus}}
 
{{About0|West nile virus}}
 
{{CMG}}
 
==Overview==
WNV is an enveloped positive-sense ssRNA virus of 11000 base pairs (bp) that is considered a member of the Japanese encephalitis serocomplex. It belongs to the genus Flavivirus and family Flaviviridae. Its RNA encodes structural and non-structural proteins. Although 7 lineages of WNV have been described, only lineage 1 and 2 are clinically significant. The viral natural reservoir includes many species, such as humans, horses, dogs, and cats; but the main natural reservoir is birds.
 
==Taxonomy==
Viruses; ssRNA viruses; ssRNA positive-strand viruses, no DNA stage; Flaviviridae; Flavivirus; Japanese encephalitis virus group<ref name=NCBI>{{cite web | title = West Nile Virus | url = http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&id=11082&lvl=3&lin=f&keep=1&srchmode=1&unlock }}</ref>
 
==Biology==
 
{| style="float: right;"
 
|
 
[[
 
File:WNV.jpg|200px|thumb|none| Digitally-colorized transmission electron micrograph (TEM) of the West Nile virus (WNV).<SMALL> ''Image provided by the CDC [http://phil.cdc.gov/phil/details.asp Centers for Disease Control and Prevention] ''<ref>{{Cite web | title = http://phil.cdc.gov/phil/details.asp | url = http://phil.cdc.gov/phil/details.asp}}</ref></SMALL>]]
|-
| [[File:WNV2.jpg|200px|thumb|none| Presence of West Nile virus virions, in an isolate that was grown in a cell culture.<SMALL> ''Image provided by the CDC [http://phil.cdc.gov/phil/details.asp Centers for Disease Control and Prevention] ''<ref>{{Cite web | title = http://phil.cdc.gov/phil/details.asp | url = http://phil.cdc.gov/phil/details.asp}}</ref></SMALL>]]
|}
WNV is a member of Japanese encephalitis serocomplex and belongs to the [[genus]] [[Flavivirus]], family [[Flaviviridae]].  Other [[species]] of the this serocomplex include the [[St Louis encephalitis virus]] and the [[Japanese encephalitis virus]].<ref name="pmid23860989">{{cite journal| author=Petersen LR, Brault AC, Nasci RS| title=West Nile virus: review of the literature. | journal=JAMA | year= 2013 | volume= 310 | issue= 3 | pages= 308-15 | pmid=23860989 | doi=10.1001/jama.2013.8042 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23860989  }} </ref>
 
The WNV has an icosahedral symmetry, with a smooth surface.<ref name="Mukhopadhyay2003">{{cite journal|last1=Mukhopadhyay|first1=S.|title=Structure of West Nile Virus|journal=Science|volume=302|issue=5643|year=2003|pages=248–248|issn=0036-8075|doi=10.1126/science.1089316}}</ref>  It is an enveloped virus with a nucleocapsid core built of [[RNA]] and [[capsid]] proteins.  Its [[genome]] is contained in a single-stranded [[RNA]] of about 11000 bp.<ref name="CampbellMarfin2002">{{cite journal|last1=Campbell|first1=Grant L|last2=Marfin|first2=Anthony A|last3=Lanciotti|first3=Robert S|last4=Gubler|first4=Duane J|title=West Nile virus|journal=The Lancet Infectious Diseases|volume=2|issue=9|year=2002|pages=519–529|issn=14733099|doi=10.1016/S1473-3099(02)00368-7}}</ref>  It contains a single open reading frame ([[ORF]]), a 5' untranslated region ([[UTR]]), and another 3' region which is also not translated. The ORF contains a single polyprotein that produces 3 smaller types of structure proteins and 7 of non-structural proteins following processing and translation.
* Structural proteins are responsible for the formation of the viral particle and include:
:* Envelope proteins
:* Membrane proteins
:* C proteins
* Non-structural proteins are responsible for viral replication, evasion of the immune system, and assembly of virions. They include:
:*NS1
:*NS2A
:*NS2B
:*NS3
:*NS4A
:*NS4B
:*NS5
 
The WNV may be classified in 7 phylogenetic lineages.  Of these, only 1 and 2 have been identified as causative agents of disease in humans and are considered clinically significant.<ref name=CDC>{{cite web | title = West Nile Virus | url = http://wwwnc.cdc.gov/eid/article/10/1/pdfs/02-0616.pdf }}</ref><ref name="pmid12890319">{{cite journal| author=Miller DL, Mauel MJ, Baldwin C, Burtle G, Ingram D, Hines ME et al.| title=West Nile virus in farmed alligators. | journal=Emerg Infect Dis | year= 2003 | volume= 9 | issue= 7 | pages= 794-9 | pmid=12890319 | doi=10.3201/eid0907.030085 | pmc=PMC3023431 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12890319  }} </ref><ref name="pmid16704810">{{cite journal| author=Bakonyi T, Ivanics E, Erdélyi K, Ursu K, Ferenczi E, Weissenböck H et al.| title=Lineage 1 and 2 strains of encephalitic West Nile virus, central Europe. | journal=Emerg Infect Dis | year= 2006 | volume= 12 | issue= 4 | pages= 618-23 | pmid=16704810 | doi=10.3201/eid1204.051379 | pmc=PMC3294705 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16704810  }} </ref><ref name="pmid14585341">{{cite journal| author=Charrel RN, Brault AC, Gallian P, Lemasson JJ, Murgue B, Murri S et al.| title=Evolutionary relationship between Old World West Nile virus strains. Evidence for viral gene flow between Africa, the Middle East, and Europe. | journal=Virology | year= 2003 | volume= 315 | issue= 2 | pages= 381-8 | pmid=14585341 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14585341  }} </ref><ref name="pmid12093177">{{cite journal| author=Lanciotti RS, Ebel GD, Deubel V, Kerst AJ, Murri S, Meyer R et al.| title=Complete genome sequences and phylogenetic analysis of West Nile virus strains isolated from the United States, Europe, and the Middle East. | journal=Virology | year= 2002 | volume= 298 | issue= 1 | pages= 96-105 | pmid=12093177 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12093177  }} </ref><ref name="pmid21781205">{{cite journal| author=Papa A, Xanthopoulou K, Gewehr S, Mourelatos S| title=Detection of West Nile virus lineage 2 in mosquitoes during a human outbreak in Greece. | journal=Clin Microbiol Infect | year= 2011 | volume= 17 | issue= 8 | pages= 1176-80 | pmid=21781205 | doi=10.1111/j.1469-0691.2010.03438.x | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21781205  }} </ref><ref name="pmid22406344">{{cite journal| author=Savini G, Capelli G, Monaco F, Polci A, Russo F, Di Gennaro A et al.| title=Evidence of West Nile virus lineage 2 circulation in Northern Italy. | journal=Vet Microbiol | year= 2012 | volume= 158 | issue= 3-4 | pages= 267-73 | pmid=22406344 | doi=10.1016/j.vetmic.2012.02.018 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22406344  }} </ref><ref name="pmid21586266">{{cite journal| author=Valiakos G, Touloudi A, Iacovakis C, Athanasiou L, Birtsas P, Spyrou V et al.| title=Molecular detection and phylogenetic analysis of West Nile virus lineage 2 in sedentary wild birds (Eurasian magpie), Greece, 2010. | journal=Euro Surveill | year= 2011 | volume= 16 | issue= 18 | pages=  | pmid=21586266 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21586266  }} </ref>
* Lineage 1: Widespread, isolates from Europe, America, Middle East, India, Africa, and Australia
* Lingeage 2: Southern Africa, Madagascar, and Europe
 
==Natural reservoir==
Although WNV can infect humans and numerous animals, birds are its main [[natural reservoir]].<ref name="pmid23860989">{{cite journal| author=Petersen LR, Brault AC, Nasci RS| title=West Nile virus: review of the literature. | journal=JAMA | year= 2013 | volume= 310 | issue= 3 | pages= 308-15 | pmid=23860989 | doi=10.1001/jama.2013.8042 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23860989  }} </ref><ref name="CampbellMarfin2002">{{cite journal|last1=Campbell|first1=Grant L|last2=Marfin|first2=Anthony A|last3=Lanciotti|first3=Robert S|last4=Gubler|first4=Duane J|title=West Nile virus|journal=The Lancet Infectious Diseases|volume=2|issue=9|year=2002|pages=519–529|issn=14733099|doi=10.1016/S1473-3099(02)00368-7}}</ref>
 
==Gallery==
 
<gallery>
 
Image: Flavivirus13.jpeg| West Nile virus is a flavivirus commonly found in Africa, West Asia, and the Middle East. <SMALL><SMALL>''[http://phil.cdc.gov/phil/home.asp From Public Health Image Library (PHIL).] ''<ref name=PHIL> {{Cite web | title = Public Health Image Library (PHIL) | url = http://phil.cdc.gov/phil/home.asp}}</ref></SMALL></SMALL>
 
Image: Flavivirus12.jpeg| This is a transmission electron micrograph (TEM) of the West Nile virus (WNV). <SMALL><SMALL>''[http://phil.cdc.gov/phil/home.asp From Public Health Image Library (PHIL).] ''<ref name=PHIL> {{Cite web | title = Public Health Image Library (PHIL) | url = http://phil.cdc.gov/phil/home.asp}}</ref></SMALL></SMALL>
</gallery>
 
Image: Flavivirus06.jpeg| Digitally-colorized transmission electron micrograph (TEM) of the West Nile virus (WNV). <SMALL><SMALL>''[http://phil.cdc.gov/phil/home.asp From Public Health Image Library (PHIL).] ''<ref name=PHIL> {{Cite web | title = Public Health Image Library (PHIL) | url = http://phil.cdc.gov/phil/home.asp}}</ref></SMALL></SMALL>
 
</gallery>
 
==References==
{{Reflist|2}}

Revision as of 13:37, 12 August 2015

Most boils run their course within 4 to 10 days. For most people, self-care by applying a warm compress or soaking the boil in warm water can help alleviate the pain and hasten draining of the pus (colloquially referred to as "bringing the boil to a head"). Once the boil drains, the area should be washed with antibacterial soap and bandaged well.

For recurring cases, sufferers may benefit from diet supplements of Vitamin A and E.

In serious cases, prescription oral antibiotics such as dicloxacillin (Dynapen) or cephalexin (Keflex), or topical antibiotics, are commonly used. For patients allergic to penicillin-based drugs, erythromycin (E-base, Erycin) may also be used.

However, some boils are caused by a super bug known as Community-Associated Methicillin-Resistant Staphylococcus Aureus, or CA-MRSA. Bactrim or other sulfa drugs must be prescribed relatively soon after boil has started to form. MRSA tends to increase the speed of growth of the infection.

Magnesium sulfate paste applied to the affected area can prevent the growth of bacteria and reduce boils by absorbing pus and drying up the lesion.

  • Abx
  • Mupirocin 2% ointment to anterior nares bid x 5 days
  • Eliminates S. aureus nasal carriage for up to 90 days
  • Also effective against MRSA, but 40% recur on maintenance Rx
  • Eliminates nasal carriage for up to 3 months
  • Consider in patients who have failed other preventive measures
  • Rx acute recurrence simultaneously with dicloxacillin or alternative x 10d
  • Clindamycin 150 mg po qd x 3 months (suppressive regimen)
  • Shown in one study to decrease frequency of recurrence

References


Template:WikiDoc Sources